HEADER TRANSFERASE 18-JAN-19 6NPV
TITLE C-ABL KINASE DOMAIN WITH THE ACTIVATOR(CMPD51), N-(1-(3,4-
TITLE 2 DICHLOROPHENYL)-4-(2-HYDROXYETHYL)-4,5-DIHYDRO-1H-PYRAZOL-3-YL)
TITLE 3 ISONICOTINAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON
COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150;
COMPND 6 EC: 2.7.10.2;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: ABL1, ABL, JTK7;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790
KEYWDS ACTIVATOR, KINASE, ALLOSTERIC, SIGNALING PROTEIN, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.CAMPOBASSO
REVDAT 2 13-MAR-24 6NPV 1 HETSYN
REVDAT 1 13-MAR-19 6NPV 0
JRNL AUTH G.L.SIMPSON,S.M.BERTRAND,J.A.BORTHWICK,N.CAMPOBASSO,
JRNL AUTH 2 J.CHABANET,S.CHEN,J.COGGINS,J.COTTOM,S.B.CHRISTENSEN,
JRNL AUTH 3 H.C.DAWSON,H.L.EVANS,A.N.HOBBS,X.HONG,B.MANGATT,
JRNL AUTH 4 J.MUNOZ-MURIEDAS,A.OLIFF,D.QIN,P.SCOTT-STEVENS,P.WARD,
JRNL AUTH 5 Y.WASHIO,J.YANG,R.J.YOUNG
JRNL TITL IDENTIFICATION AND OPTIMIZATION OF NOVEL SMALL C-ABL KINASE
JRNL TITL 2 ACTIVATORS USING FRAGMENT AND HTS METHODOLOGIES.
JRNL REF J. MED. CHEM. V. 62 2154 2019
JRNL REFN ISSN 1520-4804
JRNL PMID 30689376
JRNL DOI 10.1021/ACS.JMEDCHEM.8B01872
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH J.YANG,N.CAMPOBASSO,M.P.BIJU,K.FISHER,X.Q.PAN,J.COTTOM,
REMARK 1 AUTH 2 S.GALBRAITH,T.HO,H.ZHANG,X.HONG,P.WARD,G.HOFMANN,
REMARK 1 AUTH 3 B.SIEGFRIED,F.ZAPPACOSTA,Y.WASHIO,P.CAO,J.QU,S.BERTRAND,
REMARK 1 AUTH 4 D.Y.WANG,M.S.HEAD,H.LI,S.MOORES,Z.LAI,K.JOHANSON,G.BURTON,
REMARK 1 AUTH 5 C.ERICKSON-MILLER,G.SIMPSON,P.TUMMINO,R.A.COPELAND,A.OLIFF
REMARK 1 TITL DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE,
REMARK 1 TITL 2 SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE
REMARK 1 TITL 3 MYRISTOYL BINDING SITE.
REMARK 1 REF CHEM. BIOL. V. 18 177 2011
REMARK 1 REFN ISSN 1879-1301
REMARK 1 DOI 10.1016/J.CHEMBIOL.2010.12.013
REMARK 2
REMARK 2 RESOLUTION. 1.86 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.72
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 70102
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.183
REMARK 3 R VALUE (WORKING SET) : 0.182
REMARK 3 FREE R VALUE : 0.207
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990
REMARK 3 FREE R VALUE TEST SET COUNT : 3496
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 45.7301 - 5.4305 0.99 2844 158 0.1887 0.2094
REMARK 3 2 5.4305 - 4.3114 0.99 2742 142 0.1635 0.1830
REMARK 3 3 4.3114 - 3.7667 1.00 2694 156 0.1582 0.1922
REMARK 3 4 3.7667 - 3.4224 1.00 2703 115 0.1687 0.1993
REMARK 3 5 3.4224 - 3.1772 0.99 2680 143 0.1841 0.1895
REMARK 3 6 3.1772 - 2.9899 1.00 2660 149 0.1810 0.1976
REMARK 3 7 2.9899 - 2.8402 1.00 2677 148 0.1890 0.2553
REMARK 3 8 2.8402 - 2.7166 1.00 2671 129 0.1853 0.1843
REMARK 3 9 2.7166 - 2.6120 1.00 2644 147 0.1862 0.2402
REMARK 3 10 2.6120 - 2.5219 1.00 2648 143 0.1844 0.2285
REMARK 3 11 2.5219 - 2.4430 1.00 2675 127 0.1891 0.2021
REMARK 3 12 2.4430 - 2.3732 1.00 2632 142 0.1824 0.2020
REMARK 3 13 2.3732 - 2.3107 1.00 2677 127 0.1801 0.1889
REMARK 3 14 2.3107 - 2.2544 1.00 2633 146 0.1772 0.2068
REMARK 3 15 2.2544 - 2.2031 1.00 2624 139 0.1788 0.1898
REMARK 3 16 2.2031 - 2.1562 1.00 2676 129 0.1778 0.1845
REMARK 3 17 2.1562 - 2.1131 1.00 2652 143 0.1795 0.1978
REMARK 3 18 2.1131 - 2.0732 1.00 2622 157 0.1775 0.1784
REMARK 3 19 2.0732 - 2.0362 1.00 2643 130 0.1876 0.2109
REMARK 3 20 2.0362 - 2.0017 1.00 2646 147 0.1885 0.2451
REMARK 3 21 2.0017 - 1.9694 1.00 2606 134 0.2065 0.2159
REMARK 3 22 1.9694 - 1.9391 1.00 2659 141 0.2105 0.2462
REMARK 3 23 1.9391 - 1.9106 1.00 2622 140 0.2279 0.2453
REMARK 3 24 1.9106 - 1.8837 1.00 2660 125 0.2382 0.2836
REMARK 3 25 1.8837 - 1.8600 1.00 2616 139 0.2597 0.3103
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.330
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 23.01
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.61
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.007 4530
REMARK 3 ANGLE : 0.930 6120
REMARK 3 CHIRALITY : 0.054 629
REMARK 3 PLANARITY : 0.005 773
REMARK 3 DIHEDRAL : 10.300 3171
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6NPV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-19.
REMARK 100 THE DEPOSITION ID IS D_1000239188.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-AUG-09
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 21-ID-F
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9787
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70192
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860
REMARK 200 RESOLUTION RANGE LOW (A) : 74.970
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 6.200
REMARK 200 R MERGE (I) : 0.09900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 6.20
REMARK 200 R MERGE FOR SHELL (I) : 0.77400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHENIX
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.56
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1 - 3 % PEG 400 0.1 HEPES PH 7.5 2M
REMARK 280 AMSO4, VAPOR DIFFUSION, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.48650
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.68050
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.64350
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.68050
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.48650
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.64350
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 234
REMARK 465 HIS A 235
REMARK 465 HIS A 236
REMARK 465 HIS A 237
REMARK 465 HIS A 238
REMARK 465 HIS A 239
REMARK 465 HIS A 240
REMARK 465 GLU A 241
REMARK 465 ASN A 242
REMARK 465 LEU A 243
REMARK 465 TYR A 244
REMARK 465 PHE A 245
REMARK 465 GLN A 246
REMARK 465 GLY A 247
REMARK 465 SER A 248
REMARK 465 PRO A 249
REMARK 465 ASN A 250
REMARK 465 GLU A 294
REMARK 465 ASP A 295
REMARK 465 THR A 296
REMARK 465 MET A 297
REMARK 465 GLU A 298
REMARK 465 SER A 520
REMARK 465 ILE A 521
REMARK 465 SER A 522
REMARK 465 ASP A 523
REMARK 465 GLU A 524
REMARK 465 VAL A 525
REMARK 465 GLU A 526
REMARK 465 LYS A 527
REMARK 465 GLU A 528
REMARK 465 LEU A 529
REMARK 465 GLY A 530
REMARK 465 LYS A 531
REMARK 465 MET B 234
REMARK 465 HIS B 235
REMARK 465 HIS B 236
REMARK 465 HIS B 237
REMARK 465 HIS B 238
REMARK 465 HIS B 239
REMARK 465 HIS B 240
REMARK 465 GLU B 241
REMARK 465 ASN B 242
REMARK 465 LEU B 243
REMARK 465 TYR B 244
REMARK 465 PHE B 245
REMARK 465 GLN B 246
REMARK 465 GLY B 247
REMARK 465 SER B 248
REMARK 465 PRO B 249
REMARK 465 ASN B 250
REMARK 465 TYR B 251
REMARK 465 LYS B 293
REMARK 465 GLU B 294
REMARK 465 ASP B 295
REMARK 465 THR B 296
REMARK 465 MET B 297
REMARK 465 GLU B 298
REMARK 465 LEU B 403
REMARK 465 SER B 404
REMARK 465 ARG B 405
REMARK 465 LEU B 406
REMARK 465 MET B 407
REMARK 465 THR B 408
REMARK 465 GLY B 409
REMARK 465 ASP B 410
REMARK 465 THR B 411
REMARK 465 TYR B 412
REMARK 465 THR B 413
REMARK 465 ALA B 414
REMARK 465 HIS B 415
REMARK 465 ALA B 416
REMARK 465 GLY B 417
REMARK 465 GLY B 530
REMARK 465 LYS B 531
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 TYR A 251 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 ARG A 258 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 326 CD NE CZ NH1 NH2
REMARK 470 THR A 408 OG1 CG2
REMARK 470 ASP A 410 CG OD1 OD2
REMARK 470 LYS A 434 CD CE NZ
REMARK 470 GLU B 327 CG CD OE1 OE2
REMARK 470 LYS B 375 CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 NH2 ARG B 258 O PRO B 329 2.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 252 -160.20 -103.62
REMARK 500 LYS A 264 -142.76 -109.12
REMARK 500 ARG A 381 -10.34 88.55
REMARK 500 ASP A 382 48.40 -150.65
REMARK 500 TYR A 459 54.75 39.00
REMARK 500 LYS B 264 -142.26 -106.85
REMARK 500 ARG B 381 -8.39 84.26
REMARK 500 ASP B 382 47.05 -148.26
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue STI A 602
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue KWP A 603
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 602
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue STI B 603
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 604
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 605
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 2PE B 606
REMARK 800
REMARK 800 SITE_IDENTIFIER: AD1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue KWP B 607
DBREF 6NPV A 248 531 UNP P00519 ABL1_HUMAN 229 512
DBREF 6NPV B 248 531 UNP P00519 ABL1_HUMAN 229 512
SEQADV 6NPV MET A 234 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 235 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 236 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 237 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 238 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 239 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS A 240 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLU A 241 UNP P00519 EXPRESSION TAG
SEQADV 6NPV ASN A 242 UNP P00519 EXPRESSION TAG
SEQADV 6NPV LEU A 243 UNP P00519 EXPRESSION TAG
SEQADV 6NPV TYR A 244 UNP P00519 EXPRESSION TAG
SEQADV 6NPV PHE A 245 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLN A 246 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLY A 247 UNP P00519 EXPRESSION TAG
SEQADV 6NPV MET B 234 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 235 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 236 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 237 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 238 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 239 UNP P00519 EXPRESSION TAG
SEQADV 6NPV HIS B 240 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLU B 241 UNP P00519 EXPRESSION TAG
SEQADV 6NPV ASN B 242 UNP P00519 EXPRESSION TAG
SEQADV 6NPV LEU B 243 UNP P00519 EXPRESSION TAG
SEQADV 6NPV TYR B 244 UNP P00519 EXPRESSION TAG
SEQADV 6NPV PHE B 245 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLN B 246 UNP P00519 EXPRESSION TAG
SEQADV 6NPV GLY B 247 UNP P00519 EXPRESSION TAG
SEQRES 1 A 298 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN
SEQRES 2 A 298 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR
SEQRES 3 A 298 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR
SEQRES 4 A 298 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU
SEQRES 5 A 298 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU
SEQRES 6 A 298 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU
SEQRES 7 A 298 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS
SEQRES 8 A 298 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET
SEQRES 9 A 298 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN
SEQRES 10 A 298 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA
SEQRES 11 A 298 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS
SEQRES 12 A 298 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU
SEQRES 13 A 298 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY
SEQRES 14 A 298 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS
SEQRES 15 A 298 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU
SEQRES 16 A 298 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL
SEQRES 17 A 298 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR
SEQRES 18 A 298 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL
SEQRES 19 A 298 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO
SEQRES 20 A 298 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA
SEQRES 21 A 298 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA
SEQRES 22 A 298 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER
SEQRES 23 A 298 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS
SEQRES 1 B 298 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN
SEQRES 2 B 298 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR
SEQRES 3 B 298 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR
SEQRES 4 B 298 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU
SEQRES 5 B 298 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU
SEQRES 6 B 298 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU
SEQRES 7 B 298 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS
SEQRES 8 B 298 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET
SEQRES 9 B 298 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN
SEQRES 10 B 298 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA
SEQRES 11 B 298 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS
SEQRES 12 B 298 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU
SEQRES 13 B 298 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY
SEQRES 14 B 298 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS
SEQRES 15 B 298 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU
SEQRES 16 B 298 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL
SEQRES 17 B 298 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR
SEQRES 18 B 298 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL
SEQRES 19 B 298 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO
SEQRES 20 B 298 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA
SEQRES 21 B 298 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA
SEQRES 22 B 298 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER
SEQRES 23 B 298 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS
HET SO4 A 601 5
HET STI A 602 37
HET KWP A 603 25
HET SO4 B 601 5
HET SO4 B 602 5
HET STI B 603 37
HET GOL B 604 6
HET GOL B 605 6
HET 2PE B 606 28
HET KWP B 607 25
HETNAM SO4 SULFATE ION
HETNAM STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-
HETNAM 2 STI PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE
HETNAM KWP ~{N}-[(4~{S})-2-(3,4-DICHLOROPHENYL)-4-(2-
HETNAM 2 KWP HYDROXYETHYL)-3,4-DIHYDROPYRAZOL-5-YL]PYRIDINE-4-
HETNAM 3 KWP CARBOXAMIDE
HETNAM GOL GLYCEROL
HETNAM 2PE NONAETHYLENE GLYCOL
HETSYN STI STI-571; IMATINIB
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 3 SO4 3(O4 S 2-)
FORMUL 4 STI 2(C29 H31 N7 O)
FORMUL 5 KWP 2(C17 H16 CL2 N4 O2)
FORMUL 9 GOL 2(C3 H8 O3)
FORMUL 11 2PE C18 H38 O10
FORMUL 13 HOH *261(H2 O)
HELIX 1 AA1 GLU A 257 THR A 259 5 3
HELIX 2 AA2 GLY A 268 GLN A 271 5 4
HELIX 3 AA3 LYS A 282 SER A 284 5 3
HELIX 4 AA4 GLU A 300 GLU A 311 1 12
HELIX 5 AA5 ASN A 341 CYS A 349 1 9
HELIX 6 AA6 ASN A 355 LYS A 376 1 22
HELIX 7 AA7 ALA A 384 ARG A 386 5 3
HELIX 8 AA8 GLU A 392 HIS A 394 5 3
HELIX 9 AA9 GLY A 402 LEU A 406 5 5
HELIX 10 AB1 PRO A 421 THR A 425 5 5
HELIX 11 AB2 ALA A 426 ASN A 433 1 8
HELIX 12 AB3 SER A 436 THR A 453 1 18
HELIX 13 AB4 ASP A 463 SER A 465 5 3
HELIX 14 AB5 GLN A 466 LYS A 473 1 8
HELIX 15 AB6 PRO A 484 TRP A 495 1 12
HELIX 16 AB7 ASN A 498 ARG A 502 5 5
HELIX 17 AB8 SER A 504 SER A 519 1 16
HELIX 18 AB9 GLU B 257 THR B 259 5 3
HELIX 19 AC1 GLY B 268 GLN B 271 5 4
HELIX 20 AC2 LYS B 282 SER B 284 5 3
HELIX 21 AC3 GLU B 300 LYS B 310 1 11
HELIX 22 AC4 ASN B 341 CYS B 349 1 9
HELIX 23 AC5 ASN B 355 LYS B 376 1 22
HELIX 24 AC6 ALA B 384 ARG B 386 5 3
HELIX 25 AC7 GLU B 392 HIS B 394 5 3
HELIX 26 AC8 PRO B 421 THR B 425 5 5
HELIX 27 AC9 ALA B 426 ASN B 433 1 8
HELIX 28 AD1 SER B 436 THR B 453 1 18
HELIX 29 AD2 ASP B 463 SER B 465 5 3
HELIX 30 AD3 GLN B 466 LYS B 473 1 8
HELIX 31 AD4 PRO B 484 TRP B 495 1 12
HELIX 32 AD5 ASN B 498 ARG B 502 5 5
HELIX 33 AD6 SER B 504 LEU B 529 1 26
SHEET 1 AA1 5 ILE A 261 LYS A 266 0
SHEET 2 AA1 5 VAL A 275 TRP A 280 -1 O GLU A 277 N HIS A 265
SHEET 3 AA1 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280
SHEET 4 AA1 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290
SHEET 5 AA1 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333
SHEET 1 AA2 2 CYS A 388 VAL A 390 0
SHEET 2 AA2 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389
SHEET 1 AA3 2 THR A 413 HIS A 415 0
SHEET 2 AA3 2 ALA A 418 PHE A 420 -1 O PHE A 420 N THR A 413
SHEET 1 AA4 5 ILE B 261 LYS B 266 0
SHEET 2 AA4 5 VAL B 275 TRP B 280 -1 O VAL B 279 N THR B 262
SHEET 3 AA4 5 LEU B 285 LEU B 292 -1 O LEU B 285 N TRP B 280
SHEET 4 AA4 5 PHE B 330 GLU B 335 -1 O ILE B 332 N LYS B 290
SHEET 5 AA4 5 LEU B 320 CYS B 324 -1 N LEU B 321 O ILE B 333
SHEET 1 AA5 2 CYS B 388 VAL B 390 0
SHEET 2 AA5 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389
CISPEP 1 PRO A 328 PRO A 329 0 -0.52
CISPEP 2 PRO B 328 PRO B 329 0 -5.15
SITE 1 AC1 4 ARG A 492 GLN A 496 HOH A 707 HOH A 812
SITE 1 AC2 15 LEU A 267 ALA A 288 LYS A 290 GLU A 305
SITE 2 AC2 15 MET A 309 ILE A 312 VAL A 318 THR A 334
SITE 3 AC2 15 MET A 337 ILE A 379 HIS A 380 ALA A 399
SITE 4 AC2 15 ASP A 400 PHE A 401 HOH A 781
SITE 1 AC3 10 ARG A 351 ALA A 356 ALA A 363 LEU A 448
SITE 2 AC3 10 ILE A 451 ALA A 452 TYR A 454 GLU A 481
SITE 3 AC3 10 GLY A 482 PRO A 484
SITE 1 AC4 4 ARG A 326 ARG A 479 GLU A 481 GLY A 482
SITE 1 AC5 2 LYS A 473 LYS B 313
SITE 1 AC6 16 LEU B 267 ALA B 288 LYS B 290 GLU B 305
SITE 2 AC6 16 MET B 309 ILE B 312 VAL B 318 THR B 334
SITE 3 AC6 16 PHE B 336 MET B 337 ILE B 379 HIS B 380
SITE 4 AC6 16 ALA B 399 ASP B 400 PHE B 401 HOH B 786
SITE 1 AC7 5 ASP B 474 ARG B 476 ARG B 492 TRP B 495
SITE 2 AC7 5 HOH B 764
SITE 1 AC8 8 LYS B 313 HIS B 314 PRO B 315 LEU B 471
SITE 2 AC8 8 GLU B 472 ASP B 474 ARG B 476 TRP B 497
SITE 1 AC9 7 VAL B 357 TYR B 361 ASN B 393 TYR B 432
SITE 2 AC9 7 LYS B 434 PHE B 516 SER B 520
SITE 1 AD1 11 ARG B 351 ALA B 356 ALA B 363 LEU B 448
SITE 2 AD1 11 ILE B 451 ALA B 452 TYR B 454 GLU B 481
SITE 3 AD1 11 GLY B 482 PRO B 484 HOH B 793
CRYST1 74.973 95.287 115.361 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013338 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010495 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008668 0.00000